FCX vs OGEN · P/E 38, rev $25.45B vs rev $37.7K
Freeport-McMoran Copper & Gold Inc (FCX) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the FCX and OGEN stock pages for the full models.
Not investment advice.